1824 studies found for:    bone AND (woman OR women OR female)
Show Display Options
Rank Status Study
21 Recruiting Longitudinal Lactation Bone Density Study
Conditions: Lactation;   Other Disorders of Bone Density and Structure;   Endocrine; Complications
Intervention:
22 Completed
Has Results
A Transiliac Crest Bone Histology and Histomorphometry Study in Postmenopausal Women With Low Bone Mass or Osteoporosis Previously Treated With Denosumab
Conditions: Low Bone Mass;   Low Bone Mineral Density;   Osteoporosis;   Postmenopausal Osteoporosis
Intervention: Drug: Previous denosumab
23 Completed Effect of Epidural Steroid Injection on Bone Mineral Density in Postmenopausal Women
Conditions: To Assess the Changes in Markers of Bone Turnover Over a Six Month Period After Epidural Steroid Inject;   To Assess the Changes in Bone Mineral Density.
Intervention: Drug: Triamcinilone (kenalog)
24 Completed
Has Results
Effect of Full Length Parathyroid Hormone, PTH(1-84) or Strontium Ranelate on Bone Markers in Postmenopausal Women With Primary Osteoporosis (FP-006-IM)
Condition: Osteoporosis
Interventions: Drug: Full Length Parathyroid Hormone, PTH(1-84);   Drug: Strontium Ranelate
25 Recruiting IGF-1 and Bone Loss in Women With Anorexia Nervosa
Conditions: Anorexia Nervosa;   Osteopenia;   Osteoporosis
Interventions: Drug: rhIGF-1;   Drug: Risedronate;   Drug: Placebo
26 Recruiting Bone Healing After Dental Extraction in Postmenopausal Osteoporotic Women Treated With Alendronate Per os Weekly
Condition: Alveolar Bone Healing After Dental Extraction
Intervention: Procedure: Dental extraction
27 Completed Effects of Yoga on Bone Metabolism in Premenopausal Women
Conditions: Bone Health;   Osteoporosis
Intervention: Other: Yoga Group
28 Completed The Change of Bone Markers After Low Dose Alendronate in Postmenopausal Women With Bone Loss
Condition: Osteoporosis
Intervention: Drug: Alendronate
29 Completed
Has Results
Determine the Efficacy, Safety and Tolerability of Denosumab (AMG 162) in the Treatment of Postmenopausal Women With Low Bone Mineral Density
Condition: Low Bone Mineral Density
Interventions: Drug: Placebo;   Drug: Denosumab;   Drug: Alendronate
30 Not yet recruiting Bone Healing in Healthy and Post-menopausal Osteoporotic Women
Condition: Post-menopausal Osteoporosis
Interventions: Procedure: tooth extraction;   Radiation: CBCT scan;   Radiation: DXA scan;   Radiation: Panoramic radiograph
31 Completed
Has Results
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety of Denosumab Administration in Postmenopausal Women With Low Bone Mineral Density
Condition: Low Bone Mineral Density
Intervention: Drug: AMG 162
32 Withdrawn Study to Evaluate Effect of Intranasal Teriparatide on Bone Mineral Density in Postmenopausal Women With Low BMD
Conditions: Osteopenia;   Osteoporosis
Interventions: Drug: Teriparatide;   Drug: Teriparatide Nasal Spray
33 Completed The Effectiveness of Individualised Bone Density Feedback and Osteoporosis Education in Premenopausal Women
Condition: Osteoporosis
Intervention: Behavioral: individualised bone density feedback and education
34 Completed Effects of Continuous Combined Hormone Replacement Therapy and Clodronate on Bone Mineral Density (BMD) in Osteoporotic Women
Condition: Osteoporosis
Interventions: Drug: Klodronate and Kliogest;   Procedure: Placebo+ Kliogest;   Drug: Bonefos
35 Completed Effects of Phytoestrogen-Rich Diets on Bone Turnover in Postmenopausal Women
Condition: Osteoporosis
Intervention: Drug: Isoflavones-enriched foods
36 Enrolling by invitation Bone Metabolism After Bariatric Surgery
Conditions: Obesity;   Osteoporosis
Intervention:
37 Completed Study to Assess Efficacy of Risedronate in Preventing Bone Loss in Postmenopausal Women Treated for Breast Cancer
Conditions: Breast Cancer;   Menopause;   Osteopenia
Interventions: Drug: Risedronate;   Drug: Placebo
38 Completed
Has Results
Study In Postmenopausal Women With Type 2 Diabetes Looking At Approved Diabetes Drugs And How They Affect Bone Health
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Rosiglitazone;   Drug: Metformin
39 Active, not recruiting A Pilot Study of Bone Mineral Density in Postmenopausal Women After Treatment for Breast Cancer
Conditions: Postmenopausal Bone Loss;   Breast Cancer
Intervention:
40 Active, not recruiting Forteo for the Treatment of Unexplained Osteoporosis in Premenopausal Women
Conditions: Premenopause;   Low Bone Density;   Fracture;   Osteoporosis
Intervention: Drug: Teriparatide (PTH 1-34)

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years